Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly to Provide Detailed Review of Elanco Animal Health and Alzheimer's R&D Strategy at Investment Community Meeting
Yahoo
Fri, 11/20/15 - 10:42 am
Tags:
Eli Lilly, Elanco, animal health, Alzheimer's disease, R&D
It's payers vs. pharma and vice versa as Washington targets drug prices
Fierce Pharma
Mon, 11/16/15 - 10:28 pm
Tags:
drug pricing, payers, Pfizer, Eli Lilly, PhRMA
Drug makers beat diabetes lawsuits with an unusual ruling
Pharmalot
Fri, 11/13/15 - 08:49 pm
Tags:
diabetes, FDA, labeling, Merck, Novo Nordisk, Eli Lilly
Victoza Brings About No Effects To Help Control Heart Failure
Bidness, ETC
Tue, 11/10/15 - 03:54 pm
Tags:
diabetes, heart failure, Jardiance, Victoza, Novo Nordisk, Eli Lilly, Boehringer Ingelheim
Lilly, Merck join Valeant in DOJ spotlight with new inquiries on pricing
Fierce Pharma
Tue, 11/10/15 - 09:33 am
Tags:
Eli Lilly, Merck, Valeant Pharmaceuticals, DOS, drug pricing
Lilly diabetes drug cuts heart failure death, hospitalization -study
Yahoo/Reuters
Mon, 11/9/15 - 03:33 pm
Tags:
Eli Lilly, Jardiance, diabetes, heart failure, Boehringer Ingelheim
Eli Lilly and Company Announces Expansion of Indianapolis R&D Headquarters
Yahoo
Mon, 11/2/15 - 08:11 am
Tags:
Eli Lilly, R&D
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Tags:
Eli Lilly, GSK, AstraZeneca, Shire, Celladon, Takeda, Merck, Roche, Verastem, evacetrapib, Breo Ellipta, brodalumab, selumetinib, SHP625, Mydicar, Alisertib, suggammadex, sembragiline, Defactinib
Eli Lilly CEO: Our Drug Prices are Fair
FOX Business
Thu, 10/22/15 - 07:24 pm
Tags:
Eli Lilly, Pharma CEOs, John Lechleiter, drug pricing
Lilly beats forecasts on cost cuts, raises 2015 view
Yahoo/Reuters
Thu, 10/22/15 - 09:45 am
Tags:
Eli Lilly, earnings
What to Expect From Eli Lilly Earnings
Yahoo/24-7 Wall St
Wed, 10/21/15 - 05:36 pm
Tags:
Eli Lilly, earnings
Can Eli Lilly & Co. Recover From Expensive Failures?
Motley Fool
Tue, 10/20/15 - 09:56 am
Tags:
Eli Lilly, capital allocation, evacetrapib
One year after FDA nod, Eli Lilly's Trulicity launches first consumer campaign
Fierce Pharma Marketing
Mon, 10/19/15 - 11:07 am
Tags:
FDA, Eli Lilly, Trulicity, diabetes, drug ads
Has Eli Lilly Become the Poster Child for Failure?
Motley Fool
Fri, 10/16/15 - 07:47 pm
Tags:
Eli Lilly, clinical trials
Merck’s CETP inhibitor seems to have very low chances of success after Eli Lilly’s similar drug failed in its late stages
Bidness, ETC
Thu, 10/15/15 - 09:41 am
Tags:
Merck, Eli Lilly, CETP inhibitors, Anacetrapib, evacetrapib
Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases
Forbes
Wed, 10/14/15 - 02:15 pm
Tags:
FCPA, bribery, GSK, Bristol-Myers Squibb, Teva Pharmaceutical, Sanofi, AstraZeneca, UCB Pharma, Novartis, Novo Nordisk, Eli Lilly
Merck cholesterol drug's odds dim after Lilly failure
Yahoo/Reuters
Tue, 10/13/15 - 09:48 am
Tags:
Merck, Eli Lilly, Anacetrapib, evacetrapib
Did Amgen Waste $300 Million In Buying A Flawed Heart Drug?
Forbes
Mon, 10/12/15 - 01:39 pm
Tags:
Amgen, Eli Lilly, evacetrapib, CETP inhibitors, Dezima, TA-8995
Lilly Loses Its Bloom; Amgen, Regeneron Blossom
Barron's
Mon, 10/12/15 - 11:51 am
Tags:
Eli Lilly, Amgen, Regeneron, evacetrapib, Repatha
Eli Lilly's Good Cholesterol Drug Went Bad. Here's What That Means For Pharma
Forbes
Mon, 10/12/15 - 11:45 am
Tags:
Eli Lilly, evacetrapib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.